Growth Equity Opportunities V, LLC [Rocket]

Date Filed	Type	Description
05/12/2023	SC 13D/A	Growth Equity Opportunities V, LLC reports a 10% stake in Regulus Therapeutics Inc.
03/09/2023	SC 13D/A	Growth Equity Opportunities V, LLC has filed a Schedule 13D for MEI Pharma, Inc.
07/22/2022	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
06/17/2022	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/09/2021	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
11/19/2021	SC 13D/A	Growth Equity Opportunities V, LLC has filed a Schedule 13D for Trillium Therapeutics Inc.
08/31/2021	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
03/12/2020	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/13/2020	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/04/2020	SC 13D/A	Growth Equity Opportunities V, LLC reports a 8.7% stake in Trillium Therapeutics Inc.
12/30/2019	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
05/15/2019	SC 13D/A	Growth Equity Opportunities V, LLC reports a 10% stake in Regulus Therapeutics Inc.
03/04/2019	SC 13D/A	Growth Equity Opportunities V, LLC reports a 10% stake in Trillium Therapeutics Inc.
05/23/2018	SC 13D	Growth Equity Opportunities V, LLC reports a 10% stake in MEI Pharma, Inc.
02/20/2018	SC 13D	Form SC 13D - General statement of acquisition of beneficial ownership:
12/05/2017	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
08/02/2017	SC 13D	Form SC 13D - General statement of acquisition of beneficial ownership: